US Democrats get health sector funding

5 November 2007

US Senator Hillary Clinton (Democrat, New York) has "amassed" $2.7 million in campaign donations from the health care industry, including drugmakers, in figures released by the Campaign for Responsive Politics, an advocacy groups which tracks campaign finance. According to the New York Times, the push towards the junior Senator for New York State is a dramatic reversal from previous electoral cycles. However, in her successful re-election campaign last year, Sen Clinton also secured more funds from the drug industry than any other politician apart from Sen Rick Santorum (Republican, Pennsylvania; Marketletter July 24, 2006) who was defeated.

Philip Blando, a policy adviser whose clients include biotechnology and health insurance firms, told the NY Times: "for many people in the industry, these contributions are a defensive measure. Health care is the number one domestic policy issue, and they want access, a seat at the table."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight